BMJ, pages l4898
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jeff Land
1, 2
,
Jelena Savović
1, 3
,
Matthew J. Page
4
,
Roy G. Elbers
1
,
Natalie S. Blencowe
1, 2
,
Isabelle Boutron
5, 6, 7
,
Christopher J Cates
8
,
Hung-Yuan Cheng
1, 2
,
Mark S Corbett
9
,
Sandra M Eldridge
10
,
Jonathan R. Emberson
11
,
Miguel A. Hernán
12
,
Sally Hopewell
13
,
Asbjørn Hróbjartsson
14, 15, 16
,
Daniela R. Junqueira
17
,
Peter Jüni
18
,
Jamie J Kirkham
19
,
Toby Lasserson
20
,
Tianjing Li
21
,
Alexandra McAleenan
1
,
Barnaby C. Reeves
2, 22
,
Sasha Shepperd
23
,
Ian Shrier
24
,
Lesley A Stewart
9
,
Kate Tilling
1, 2, 25
,
Ian R. White
26
,
Penny F Whiting
1, 3
,
Julian P.T. Higgins
1, 2, 3
2
NIHR Bristol Biomedical Research Centre, Bristol, UK
|
7
Cochrane France, Paris, France
|
20
Editorial and Methods Department, Cochrane Central Executive, London, UK
|
Publication type: Journal Article
Publication date: 2019-08-28
General Engineering
Abstract
Assessment of risk of bias is regarded as an essential component of a systematic review on the effects of an intervention. The most commonly used tool for randomised trials is the Cochrane risk-of-bias tool. We updated the tool to respond to developments in understanding how bias arises in randomised trials, and to address user feedback on and limitations of the original tool.
Found
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.